About the Institute for Genomics and Multiscale Biology
The Institute for Genomics and Multiscale Biology is the hub of genomics research at Icahn School of Medicine, collaborating with our 13 other disease-oriented and core-technology-based institutes. One of the world’s foremost experts in computational biology, Eric Schadt, PhD is Director of the Institute, in addition to his continued role as SAB Member/Scientific Advisor of Pacific Biosciences. This one-of-a-kind bi-coastal collaboration is intended to greatly advance clinical research.
As part of the collaboration, a Single Molecule Real Time (SMRT™) Biology User Facility will be established within the Institute. Developed by Pacific Biosciences, SMRT technology allows for the real-time analysis of biomolecules with single molecule resolution, providing a window into biological processes that has not previously been open for study.
The large-scale generation and integration of multiple sources of biological data combined with clinical information will expand Mount Sinai’s ability to characterize disease, and ultimately help develop and improve the diagnosis and treatment of patients. With unprecedented access to Pacific Biosciences’ revolutionary technology and under the direction of Dr. Schadt, the Institute for Genomics and Multiscale Biology will be at the forefront of the revolution in genetics and genomic sciences, which will fundamentally change the practice of medicine.